Among these, telmisartan (TEL) was shown to exert favourable metabolic benefits by preventing hypothalamic inflammation [117] and by enhancing leptin transport through the BBB [118], thus restoring leptin sensitivity [115] and counteracting the development of obesity under excess nutrient intake [118]. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.